Research news

UCLH consultant urological surgeon Veeru Kasivisvanathan has been awarded the prestigious Society of Apothecaries’ 2026 William Farr Medal in recognition of his work to advance prostate cancer care globally.

There are now seven patients participating in the GB-PRIME study involving Neuralink’s brain-computer interface (BCI) technology, which aims to improve independence for people who are paralysed. 

Men with high-risk, locally advanced prostate cancer in England will soon be offered the drug abiraterone on the NHS, following landmark findings from a clinical trial co-led by an oncology consultant at UCLH.

A new scan could improve how millions of people with high blood pressure are treated, suggests a new study led by UCL and conducted at UCLH.